These advantages allow a reduction of the doses and of the levels of risk of diverse secondary effects.
Spanish patent application filed
Dr Jose Pablo Zamorano
Life Sciences Licensing Coordinator
Spanish public research organisation with 126 centres covering all knowledge areas and highly active in collaborating with the industry.View profile
Clients in focus...